Back to search
Antibody Mediated Rejection After Kidney Transplantation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection After Kidney Transplantation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection After Kidney Transplantation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This clinical trial aims to determine whether a bispecific T-cell engager (BiTE) targeting BCMA×CD3 effectively treats chronic active antibody-mediated rejectio…
Humoral rejection of kidney transplants is responsible for a large number of kidney graft losses in a context of increasing shortage. Although it has been esta…
The primary objective of this study is to evaluate the efficacy of ALXN2030 compared with placebo on biopsy proven histologic resolution in participants with ac…
Antibody mediated rejection (ABMR) is a major cause of graft loss after kidney transplantation (KT) and is mainly associated with preformed anti-HLA donor speci…